Treatments and drugsBy Mayo Clinic Staff
Your treatment options for invasive lobular carcinoma depend on the aggressiveness of your cancer, its stage, your overall health and your preferences. Treatment often consists of surgery and additional (adjuvant) therapy, which may include chemotherapy, radiation and hormone therapy.
Surgery for invasive lobular carcinoma may include:
Removing the cancer and small portion of healthy tissue. Called a lumpectomy (wide local excision), this procedure allows you to keep most of your breast tissue.
The surgeon removes the tumor itself, as well as a margin of normal tissue surrounding the tumor to make sure all the cancer that can be removed is taken out.
Negative, or clean, margins reduce the chance of leaving any cancer in the breast. If the margins are positive, you may need additional surgery until negative margins are achieved. In some cases, this may mean removing the entire breast.
Removing all of the breast tissue. Mastectomy is an operation to remove all of your breast tissue. Mastectomy can be simple, meaning the surgeon removes all of the breast tissue — the lobules, ducts, fatty tissue and skin, including the nipple and areola.
Another option is a modified radical mastectomy, which involves removing all of the breast tissue, as well as the nipple and areola and lymph nodes in the nearby armpit.
Sentinel lymph node biopsy. To determine whether cancer has spread to the lymph nodes near your breast, your surgeon identifies the first lymph nodes that receive the lymph drainage from your cancer. These lymph nodes are removed and tested for breast cancer cells (sentinel node biopsy).
If no cancer is found, the chance of finding cancer in any of the remaining nodes is small and no other nodes need to be removed.
Axillary lymph node dissection. If cancer is found in the sentinel node, then your surgeon may remove additional lymph nodes in your armpit (axillary lymph node dissection).
Knowing if cancer has spread to the lymph nodes helps determine the best course of treatment, including whether you'll need chemotherapy or radiation therapy.
Chemotherapy uses drugs to destroy cancer cells. Treatment often involves receiving two or more drugs in different combinations.
Chemotherapy can be given through a vein, in pill form or both ways.
For invasive lobular carcinoma, chemotherapy is commonly used after surgery to kill any cells that may remain.
Chemotherapy can also be used before surgery to shrink a tumor that is large. For women with large breast tumors, chemotherapy before surgery may make it possible to choose lumpectomy over mastectomy.
Radiation therapy uses high-powered energy beams, such as X-rays, to kill cancer cells.
During radiation therapy, you lie on a table while a large machine moves around you directing energy beams at precise points in your breast.
Radiation therapy may be recommended after a lumpectomy. It may also be recommended after a mastectomy if your cancer was large or involved the lymph nodes.
Hormone therapy may be an option if your cancer cells are sensitive to hormones. Most invasive lobular carcinomas are hormone receptor positive, meaning they are sensitive to hormones.
A sample of your tumor cells is tested to determine whether your cancer is hormone receptor positive. If it is, hormone therapies can block your body from producing hormones or block the cancer cells' ability to use the hormones.
One class of hormone therapy drugs called selective estrogen receptor modulators (SERMs), which includes tamoxifen, can be used in women who are premenopausal and in those who have experienced menopause. Tamoxifen works by blocking estrogen from stimulating the breast tissue.
Another class of hormone therapy drugs called aromatase inhibitors is useful only in women who have experienced menopause. This class includes the drugs anastrozole (Arimidex), letrozole (Femara) and exemestane (Aromasin). The aromatase inhibitors work by substantially reducing the amount of estrogen being made in your body and breast tissue.
May 14, 2015
- Bleiweiss IJ. Pathology of breast cancer. http://www.uptodate.com/home. Accessed Jan. 10, 2015.
- Dabbs DJ. Breast Pathology. Philadelphia, Pa.: Elsevier Saunders; 2012. https://www.clinicalkey.com. Accessed Jan. 6, 2015.
- Niederhuber JE, et al, eds. Abeloff's Clinical Oncology. 5th ed. Philadelphia, Pa.: Churchill Livingstone Elsevier; 2014. https://www.clinicalkey.com. Accessed Jan. 6, 2015.
- Breast cancer. Fort Washington, Pa.: National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed Jan. 6, 2015.
- Chan AOO, et al. Risk factors for gastric cancer. http://www.uptodate.com/home. Accessed Jan. 10, 2015.
- Hot flashes and night sweats (PDQ). National Cancer Institute. http://www.cancer.gov/cancertopics/pdq/supportivecare/sweatsandhotflashes/HealthProfessional. Accessed Jan. 10, 2015.
- Breast cancer treatment (PDQ). National Cancer Institute. http://www.cancer.gov/cancertopics/pdq/treatment/breast/healthprofessional. Accessed Jan. 6, 2015.
- Breast cancer prevention (PDQ). National Cancer Institute. http://www.cancer.gov/cancertopics/pdq/prevention/breast/healthprofessional. Accessed Jan. 6, 2015.
- Morrow PK, et al. Hot flashes: A review of pathophysiology and treatment modalities. Oncologist. 2011;16:1658.
- Pruthi S (expert opinion). Mayo Clinic, Rochester, Minn. Jan. 28, 2015.
- Moynihan TJ (expert opinion). Mayo Clinic, Rochester, Minn. Jan. 30, 2015.